Bryan C. Hanson was appointed President and Chief Executive Officer and a member of the Board of Directors of Zimmer Biomet in December 2017.
Prior to joining Zimmer Biomet, Mr. Hanson served as a member of Medtronic’s Executive Committee and as Executive Vice President and Group President, Minimally Invasive Therapies Group of Medtronic, where he oversaw and provided strategic direction to that approximately $9 billion business. Prior to joining Medtronic, Mr. Hanson served as Group President, Covidien, with global responsibility for all Covidien business segments. Prior to being elevated to that newly created position, Mr. Hanson served as Group President, Medical Devices & U.S. of Covidien and prior to that, he served as Group President, Surgical Solutions and President, Energy-based Devices. Mr. Hanson began his career with Covidien in 1992. He holds a Bachelor of Science degree in Finance from Florida State University. He also completed the Kellogg School of Management Finance for Executives program in 2010 and the Harvard Executive Education in Leadership program in 2013. Mr. Hanson serves on the board of the Advanced Medical Technology Association (AdvaMed), the medical device industry’s association and is a member of the International Board Committee. He also serves on the board of AmeriCares, an emergency response and global health organization committed to saving lives and building healthier futures for people in crisis.
Didier Deltort was appointed President, Europe, Middle East and Africa in August 2018. He is responsible for the marketing, sales and distribution of products, services and solutions in the European, Middle Eastern and African (EMEA) regions.
Prior to joining Zimmer Biomet, Mr. Deltort served as Senior Vice President and General Manager, Global Healthcare Solutions and Partnerships at Boston Scientific Corporation, based in France from May 2016 until August 2018. Before joining Boston Scientific Corporation, he spent 14 years with GE Healthcare in positions of increasing responsibility in Germany, Finland, Dubai and the United States, most recently serving as Global Senior Vice President and General Manager of the global Monitoring Solutions business as well as Managing Director of GE Healthcare Finland. Prior to GE, Mr. Deltort served Philips and Hewlett-Packard as well as Marquette Electronics in various international healthcare executive roles. He holds a Master’s degree in Biomedical Engineering from University de Technologie de Compiègne, France.
Rachel Ellingson was appointed Senior Vice President and Chief Strategy Officer in April 2018.
Prior to joining the Company, Ms. Ellingson served as Vice President, Corporate Strategy and as a member of the executive leadership team at St. Jude Medical. Before joining St. Jude Medical, she served as Vice President, Business Development and Investor Relations at AGA Medical Corporation. Previously, she served in a number of leadership roles in investment banking firms, including Bank of America and Cowen & Company. Ms. Ellingson holds a Bachelor of Arts degree from the University of Rhode Island and an MBA in Finance from the University of Connecticut.
David Kunz was appointed Senior Vice President, Global Quality, Clinical and Regulatory Affairs in April 2016. He is responsible for providing strategic and operational direction to achieve Quality and Regulatory Excellence across the organization and he chairs the Company’s Quality Excellence Steering Committee.
Mr. Kunz joined the Company (then Zimmer) in 2011 as Vice President, Regulatory Affairs and Quality Assurance for the Spine division. Prior to joining Zimmer, he served as Vice President, Quality Assurance of Ecolab, where he led a supply chain network including nine chemical plants and two equipment plants. Previously, he spent 13 years at Guidant/Boston Scientific Corporation in a variety of leadership positions, most recently as the Director of Supplier Quality Assurance for the CRV Division. He began his career at the Naval Nuclear Propulsion Program Headquarters as a mechanical engineer. Mr. Kunz holds a Bachelor of Science and an MBA from the University of Minnesota. He is a certified Nuclear Engineer and previously was a certified Licensed Professional Mechanical Engineer.
Cole Lannum was appointed Senior Vice President, Investor Relations in March 2018. He is responsible for consulting with executive management on shareholder value optimization and strengthening investor communications both internally and throughout the broader investment community.
Prior to joining the Company, Mr. Lannum served as Senior Vice President, Investor Strategy and Investor Relations Officer for Mallinckrodt Pharmaceuticals. Prior to joining Mallinckrodt, he led Investor Relations at Covidien and Tyco Healthcare for nine years as Vice President and Investor Relations Officer. Mr. Lannum holds a Bachelor of Science in Business Administration from Washington University and a Master of Business Administration from Texas A&M University.
Angela Main was appointed Senior Vice President, Global Chief Compliance Officer and Associate General Counsel, Asia Pacific, in June 2015. She is responsible for the provision of compliance advice and ethical solutions to the Zimmer Biomet organization, including developing, operating and monitoring the Company’s Compliance Program.
Ms. Main served as Vice President, Legal and Compliance, Asia Pacific for Zimmer Biomet from September 2010 to June 2015. Prior to joining the Company in 2010, she worked for Covidien in Singapore, Lloyds TSB Bank plc in London and Texas Instruments in its European and Asia Pacific regional offices. She has extensive international legal and compliance experience in the healthcare, financial services and technology sectors.
Keri P. Mattox was appointed Senior Vice President, Investor Relations and Chief Communications Officer in January 2020. She is responsible for strategically integrating, aligning and driving investor relations, communications and philanthropy functions and activities.
Prior to joining the Company, Ms. Mattox served as Global Lead, Integrated Corporate Communications at W2O Group, an international healthcare-focused marketing and communications firm. There she was responsible for strategically shaping and expanding the firm’s global corporate communications, investor relations, crisis communications, M&A, board engagement and corporate social responsibility/foundation capabilities and offering. Prior to W2O, Ms. Mattox was Vice President, Corporate & Investor Relations at AmerisourceBergen, a healthcare company ranked #10 on the Fortune 500 in 2019 with nearly than $170 billion in annual revenue. She also held executive leadership team level positions at Endo International and Auxilium Pharmaceuticals and spent more than 10 years at communications agencies in leadership positions. Earlier in her career, Ms. Mattox was a reporter with Hearst Newspapers. She holds a B.A. from Boston University and an M.A. in Journalism from the University of Maryland.
Carrie Nichol was appointed Vice President, Controller and Chief Accounting Officer in October 2019.
Prior to joining Zimmer Biomet, Ms. Nichol served as Senior Vice President, Controller and Chief Accounting Officer of Endo International plc from April 2018 to September 2019. Ms. Nichol joined Endo in March 2015 as Director of Consolidations and Financial Systems and was promoted to Assistant Controller in September 2015. Prior to her tenure at Endo, Ms. Nichol served as Senior Vice President and Controller of Haas Group Inc. (now part of Wesco Aircraft Holdings, Inc.), where she led the global accounting and finance teams from June 2011 until March 2015. Ms. Nichol also played a critical role in Haas Group Inc.’s sale to Wesco Aircraft Holdings, Inc. in 2014. Prior to her employment with Haas Group Inc., Ms. Nichol was with IKON Office Solutions (now part of Ricoh Company, Ltd.) for a total of five years from June 2008 until June 2011 and from June 2003 until July 2005, having served most recently as the Director of Financial Reporting and Corporate Accounting with responsibility for all public filings and technical and corporate accounting. From December 2005 until June 2008, Ms. Nichol was with Advanced Metallurgical Group NV serving as Assistant Controller. Ms. Nichol began her career in public accounting with KPMG LLP. She is a licensed certified public accountant and holds a Bachelor of Science degree in Business Management, with a minor in Accounting, from Widener University and an MBA in Finance from Villanova University.
Chad Phipps was appointed Senior Vice President, General Counsel and Secretary in May 2007. He has global responsibility for the Company’s Legal Affairs and he serves as Secretary to the Board of Directors. Mr. Phipps also oversees the Company’s Government Affairs activities.
Mr. Phipps joined the Company (then Zimmer) in September 2003. Prior to joining Zimmer, he served as Vice President and General Counsel of L&N Sales and Marketing, Inc. in Pennsylvania and he practiced law with the firm of Morgan, Lewis & Bockius in Philadelphia, focusing on corporate and securities law, mergers and acquisitions and financial transactions. Mr. Phipps holds a Bachelor of Arts, magna cum laude, from Rollins College and a J.D. from Villanova University School of Law.
Pamela Puryear was appointed Senior Vice President, Chief Human Resources Officer in January 2019.
Dr. Puryear has extensive global leadership experience in human resources, including three years with Pfizer, where she served as Senior Vice President and Chief Talent Officer. While at Pfizer, Dr. Puryear was responsible for leadership development, talent management, learning and development, employee engagement, organizational culture, diversity and inclusion and workforce analytics. She joined Pfizer from Hospira Inc., where she spent six years as Vice President, Organization Development and Chief Talent Officer. Before joining Hospira, Dr. Puryear was an independent external organizational development consultant for 12 years. Dr. Puryear spent the first 10 years of her career in financial services in the real estate investment advisor industry. Dr. Puryear holds a Ph.D. in organizational psychology, an MBA from Harvard Business School, and a bachelor’s degree in psychology with a concentration in organizational behavior from Yale University.
Zeeshan Tariq was appointed Vice President and Chief Information Officer in July 2016.
Prior to joining the Company, Mr. Tariq spent 17 years at Medtronic, where he served in a number of positions of increasing responsibility, most recently as Vice President and Chief Information Officer, Cardiovascular Group. Prior to joining Medtronic, he worked in the Management Consulting, Systems Consulting and Banking industries. Mr. Tariq holds a Bachelor of Business Administration in Finance, Economics and Management Information Systems from the University of Nebraska; a Master of Science in Software Engineering from the University of Minnesota; and an MBA from the Carlson School of Management.
Ivan Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics, and a year later was named Group President, Global Businesses and the Americas. Prior to joining Zimmer Biomet, Mr. Tornos served as Worldwide President of the Global Urology, Medical and Critical Care Division of Becton, Dickinson and Company. Prior to that, he was with C.R. Bard in positions of increasing responsibility, most recently serving as President, Europe, Middle East and Africa Regions. Before joining C.R. Bard, Mr. Tornos served as Vice President and General Manager of the Americas Pharmaceutical and Medical/Imaging segments of Covidien International. Before that, Mr. Tornos served as International Vice President, Business Development and Strategy with Baxter International Inc. and prior to that, he spent 11 years with Johnson & Johnson.
Mr. Tornos is an alumnus of the Harvard Business School, having graduated from the Advanced Management Program and also completed leadership and management programs at the Cox School of Business of Southern Methodist University. He finalized post-MBA work at the Wharton School of the University of Pennsylvania (CPD Marketing/Finance), holds an MBA from the University of Miami School of Business and a BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business
Kenneth Tripp was appointed Senior Vice President, Global Operations and Logistics in April 2018.
Prior to joining the Company, Mr. Tripp served as Senior Vice President, Manufacturing at Cardinal Health. Prior to joining Cardinal Health, he served as the Vice President of Operations of the Patient Monitoring and Recovery business at Medtronic. Mr. Tripp is retired from 25 years of service in the U.S. Navy and U.S. Navy Reserve. Mr. Tripp holds a Bachelor of Arts in History and an MBA in Strategies in Organizational Leadership from Ashford University.
Suketu Upadhyay was appointed Executive Vice President and Chief Financial Officer in July 2019.
Prior to joining Zimmer Biomet, Mr. Upadhyay served as Senior Vice President, Global Financial Operations at Bristol-Myers Squibb from November 2016 until June 2019. Before joining Bristol-Myers Squibb, he served as Executive Vice President and Chief Financial Officer of Endo International from September 2013 to November 2016. Prior to his tenure at Endo International, Mr. Upadhyay served as Interim Chief Financial Officer as well as Senior Vice President of Finance, Corporate Controller and Principal Accounting Officer of Becton, Dickinson and Company (BD). Prior to his role as BD’s Interim Chief Financial Officer and Corporate Controller, Mr. Upadhyay was the Senior Vice President of Global Financial Planning and Analysis and also held the role of Vice President and Chief Financial Officer of BD’s international business. Before joining BD in 2010, Mr. Upadhyay held a number of leadership roles across AstraZeneca and Johnson & Johnson. These roles included the Global Head of R&D Finance, Head of Commercial Finance, Plant Controller, and Director of Business Development Finance. His experience spans over 20 years in the health care industry in financial roles of increasing responsibility covering all major areas of a fully integrated life sciences business. In addition, his experience covers businesses of varying size and scale and at different points of maturity. Mr. Upadhyay spent the early part of his career in public accounting with KPMG, and earned his CPA designation* in 1996 and his CMA designation* in 2002. He holds a Bachelor of Science in Finance from Albright College and an MBA from The Fuqua School of Business at Duke University. (* Inactive)
Sang Yi was appointed President, Asia Pacific effective June 2015. He is responsible for the sales, marketing and distribution of products in the Asia Pacific region.
Mr. Yi joined the Company (then Zimmer) in March 2013 as Senior Vice President, Asia Pacific. Before joining Zimmer, he served as Vice President and General Manager of St. Jude Medical for Asia Pacific and Australia from 2005 to 2013. Prior to that, Mr. Yi held several leadership positions over a ten-year period with Boston Scientific Corporation, ultimately serving as Vice President for North Asia. Mr. Yi holds a Bachelor of Science in Electrical Engineering from the University of South Florida.